The Norwegian Exercise in Atrial Fibrillation Trial

NAActive, not recruitingINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

February 4, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
Atrial Fibrillation
Interventions
BEHAVIORAL

Supervised home-based exercise

150-300 minutes of moderate intensity activity (55-75% of maximum heart rate in sinus rhythm or RPE 12-13 on the Borg Scale) or 75-150 minutes of vigorous intensity activity (75-90% of maximum heart rate or 14-16 on the Borg Scale) per week, or an equivalent combination of both, according to current general recommendations, including also those with established CVD. To maximize the potential for improvements in cardiorespiratory fitness, we encourage that at least 40-60 minutes per week (i.e. 2 sessions á 20-30 minutes) should be of vigorous intensity.

OTHER

Usual care

Standard management according to usual practice at the respective participating centers, including medical therapy as per guidelines. Prior to randomization all will be provided an ICM (Confirm RX™). The UC group will receive information about general PA recommendations as per guidelines at study enrollment. No further supervision is given.

Trial Locations (3)

Unknown

Vestre Viken HF, Drammen

University Hospital of North Norway, Tromsø

St Olavs Hospital, Trondheim

All Listed Sponsors
collaborator

St. Olavs Hospital

OTHER

collaborator

UiT The Arctic University of Norway

OTHER

collaborator

University Hospital of North Norway

OTHER

collaborator

Vestre Viken Hospital Trust

OTHER

lead

Norwegian University of Science and Technology

OTHER